After full adjustment, patients with a more than 16% reduction in ESVI were significantly associated with a lower risk of cardiovascular mortality in the overall cohort (HR 0.55; 95% CI, 0.39-0.78), and MED arm (HR 0.45; 95% CI, 0.27-0.74), but this association did not reach statistical significance in CABG arm (HR 0.71; 95% CI, 0.43-1.18).
← all excerpts
Left ventricular volume change and long-term outcomes in ischaemic cardiomyopathy with or without surgical revascularisation: A post-hoc analysis of a randomised controlled trial.
1
—
—